Search results
Results from the WOW.Com Content Network
The mainstay of type 1 diabetes treatment is the regular injection of insulin to manage hyperglycemia. [39] Injections of insulin via subcutaneous injection using either a syringe or an insulin pump are necessary multiple times per day, adjusting dosages to account for food intake, blood glucose levels and physical activity. [39]
Breakthrough T1D is a nonprofit 501 (c) (3) organization that funds type 1 diabetes (T1D) research, provides a broad array of community and activist services to the T1D population and actively advocates for regulation favorable to medical research and approval of new and improved treatment modalities. It was initially founded as the JDF, the ...
For premium support please call: 800-290-4726 more ways to reach us
Studies with monkeys show that injecting high-insulin-producing forms of these cells into the animals can “cure” type-1 diabetes for about six months. Human trials are underway. But a better ...
Teplizumab. Teplizumab, sold under the brand name Tzield, is a humanized anti-CD3 monoclonal antibody that is the first approved treatment indicated to delay the onset of stage 3 type 1 diabetes (T1D) in people with stage 2 T1D. [ 3][ 4][ 5] The Fc region of this antibody has been engineered to have Fc receptor non-binding (FNB) properties. [ 6]
For lack of a better phrase, those who have type 1 diabetes -- a form of diabetes whereby the person's own autoimmune system attacks or attempts to destroy cells in the pancreas responsible for ...
History of diabetes. Frederick Banting (right) joined by Charles Best in office, 1924. The condition known today as diabetes (usually referring to diabetes mellitus) is thought to have been described in the Ebers Papyrus ( c. 1550 BC ). Ayurvedic physicians (5th/6th century BC) first noted the sweet taste of diabetic urine, and called the ...
The Juvenile Diabetes Cure Alliance (JDCA) is a registered 501(c)(3) non-profit organization dedicated to developing a "Practical Cure" for type 1 diabetes.The organization advocates for increasing type 1 diabetes cure research and publishes reports on a variety of related topics, including research progress, fundraising utilization, and donor priorities.